𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon

✍ Scribed by Stefan Einhorn; Henric Blomgren; Hans Strander


Publisher
John Wiley and Sons
Year
1980
Tongue
French
Weight
866 KB
Volume
26
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The effect of daily injections of 3 Γ— 10^6^ units of human leukocyte IF on the spontaneous cytotoxicity of peripheral lymphocytes was studied in 43 patients with a variety of diseases. An increase in spontaneous cytotoxicity was observed 12 to 24 h after the first IF injection with the peak of activity occurring, in most cases, at 24 h. In some patients a decrease in spontaneous cytotoxicity, observed 6 h after the injection, preceded this increase. The increment in spontaneous cytotoxicity was not significantly correlated to preinjection level of cytotoxicity, disease, age, sex, previous therapy, leukocyte counts or proportions of lymphocytes and monocytes. A second injection of IF maintained the spontaneous cytotoxicity at an increased level and during prolonged IF therapy, up to 9 months, the cytotoxicity remained elevated. IF treatment in vitro caused an enhancement of spontaneous cytotoxicity in lymphocytes drawn prior to IF injection. This IF‐induced increase in cytotoxicity in vitro was correlated to the increase in cytototoxicity induced by IF in vivo. Six hours after the first IF injection the ability of IF in vitro to enhance spontaneous cytotoxicity was decreased and during prolonged therapy the ability of IF in vitro to enhance spontaneous cytotoxicity remained decreased.


πŸ“œ SIMILAR VOLUMES


Interferon and spontaneous cytotoxicity
✍ Stefan Einhorn; Henric Blomgren; Hans Strander πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 French βš– 719 KB

## Abstract A purified preparation of human leukocyte interferon used at this hospital in the treatment of malignant diseases was tested for its ability to modify the spontaneous cytotoxicity of peripheral lymphocytes from healthy donors. The inhibitory effect of allogeneic lymphocytes on the [^3^H

Virus infections and recurrence of osteo
✍ Snorri Ingimarsson; Gun CarlstrΓΆm; Kari Cantell; Hans Strander πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 French βš– 483 KB

## Abstract Human leukocyte interferon was given as adjuvant treatment for osteosarcoma in 26 patients. Blood from these patients was studied at regular intervals for antibodies to various micro‐organisms. A continuous record of clinically manifest infections during the course of interferon therapy

Correlation of molecular human leukocyte
✍ Helen Gogas; John M. Kirkwood; Christine S. Falk; Urania Dafni; Vernon K. Sondak πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 226 KB

## Abstract ## BACKGROUND: Interferon is approved for adjuvant treatment of patients with stage IIB/III melanoma. The identification of predictive markers that would permit selection of patients would be beneficial. Specific human leukocyte antigen (HLA) class I and II antigens have previously sho